pemafibrate
Kowa Pharmaceuticals
[]
among patients with tg, the incidence of cv events was not lower among those who received pemafibrate than among those who received placebo #prominent #aha22 
Internal Medicine Resident @bethisraellahey; Research Fellow @harvardmed @BIDMChealth; Aspiring Cardiologist; Global Environmental Health Enthusiast